The DOI matches its Crossref record; 42 of the 44 references it cites were found in a registry or an index.
Involvement of Human Micro-RNA in Growth and Response to Chemotherapy in Human Cholangiocarcinoma Cell Lines
Open accessAbstract
Background & aims Micro-RNA (miRNA) are endogenous regulatory RNA molecules that modulate gene expression. Alterations in miRNA expression can contribute to tumor growth by modulating the functional expression of critical genes involved in tumor cell proliferation or survival. Our aims were to identify specific miRNA involved in the regulation of cholangiocarcinoma growth and response to chemotherapy. Methods miRNA expression in malignant and nonmalignant human cholangiocytes was assessed using a microarray. Expression of selected miRNA and their precursors was evaluated by Northern blots and real-time polymerase chain reaction, respectively. The effect of selected miRNA on cell growth and response to chemotherapy was assessed using miRNA-specific antisense oligonucleotides to decrease miRNA expression or with precursor miRNA to increase cellular expression. Results miRNA expression was markedly different in malignant cholangiocytes, with decreased expression of many miRNA compared with nonmalignant cells. A cluster of miRNA, including miR-320, miR-200b, miR-21, miR-23a, miR-141, miR-27a, and miR-34a, were expressed in all cell lines. MiR-21, miR-141, and miR-200b were highly over-expressed in malignant cholangiocytes. Inhibition of miR-21 and miR-200b increased sensitivity to gemcitabine, whereas inhibition of miR-141 decreased cell growth. Treatment of tumor cell xenografts with systemic gemcitabine altered the expression of a significant number of miRNA. miR-21 modulates gemcitabine-induced apoptosis by phosphatase and tensin homolog deleted on chromosome 10 (PTEN)-dependent activation of PI 3-kinase signaling. Potential target genes that were modulated by selected miRNA were identified. Conclusions Alterations in miRNA expression contribute to tumor growth and response to chemotherapy. Aberrantly expressed miRNA or their targets will provide mechanistic insight and therapeutic targets for cholangiocarcinoma.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Three miR-21 targets have, thus far, been described: phosphatase and tensin homologue (PTEN), programmed cell death 4 (PDCD4) and Tropomyosin 1 (TPM1; refs.10,[14][15][16].”
From MicroRNA-21 Targets a Network of Key Tumor-Suppressive Pathways in Glioblastoma Cells (2008) · cites this paper as [10]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
MicroRNA expression profiles classify human cancers
Lü, J., Getz, G. A., Miska, E. A., Alvarez-Saavedra, E., Lamb, J., Peck, D., Sweet-Cordero, A., Ebert, B. L., Mak, R. H., Ferrando, A. A., et al. (2005) · Nature · doi:10.1038/nature03702 · Cited by 9,637
Calin, G. A., Dumitru, C. D., Shimizu, M., Bichi, R., Zupo, S., Noch, E., Aldler, H., Rattan, S., Keating, M., Rai, K., et al. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.242606799 · Cited by 5,111
TM4: a free, open-source system for microarray data management and analysis
Saeed, A. I., Sharov, V., White, J., Li, J., Liang, W., Bhagabati, N., Braisted, J., Klapa, M., Currier, T., Thiagarajan, M., et al. (2003) · BioTechniques · doi:10.2144/03342mt01 · Cited by 4,837
Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers
Calin, G. A., Sevignani, C., Dumitru, C. D., Hyslop, T., Noch, E., Yendamuri, S., Shimizu, M., Rattan, S., Bullrich, F., Negrini, M., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0307323101 · Cited by 4,096
A microRNA polycistron as a potential human oncogene
He, L., Thomson, J. M., Hemann, M. T., Hernando, E., Mu, D., Goodson, S. G., Powers, S., Cordon‐Cardo, C., Lowe, S. W., Hannon, G. J., et al. (2005) · Nature · doi:10.1038/nature03552 · Cited by 3,642
An Abundant Class of Tiny RNAs with Probable Regulatory Roles in Caenorhabditis elegans
Lau, N. C., Lim, L. P., Weinstein, E. G., & Bartel, D. P. (2001) · Science · doi:10.1126/science.1065062 · Cited by 3,345
microRNAs as oncogenes and tumor suppressors
Zhang, B., Pan, X., Cobb, G. P., & Anderson, T. A. (2006) · Developmental Biology · doi:10.1016/j.ydbio.2006.08.028 · Cited by 2,782
Modulation of Hepatitis C Virus RNA Abundance by a Liver-Specific MicroRNA
Jopling, C. L., Yi, M., Lancaster, A. M., Lemon, S. M., & Sarnow, P. (2005) · Science · doi:10.1126/science.1113329 · Cited by 2,580
MicroRNA-21 Is an Antiapoptotic Factor in Human Glioblastoma Cells
Chan, J. A., Krichevsky, A. M., & Kosik, K. S. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-0137 · Cited by 2,557
c-Myc-regulated microRNAs modulate E2F1 expression
O'Donnell, K. A., Wentzel, E. A., Zeller, K. I., Dang, C. V., & Mendell, J. T. (2005) · Nature · doi:10.1038/nature03677 · Cited by 2,347
Self-citation
Flagged first, then by citations
2 of the 44 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Items 901–983 of 983
生物信息学研究揭示乳腺癌组织分化中可能的microRNA调控通路
邵, 志., 费, 菲., 张, 学., 裴, 云., 黄, 薇., & 王, 志. (2010) · Chinese Science Bulletin (Chinese Version) · doi:10.1360/csb2010-55-8-660
Colorectal Carcinoma: Identification of MicroRNAs Using Real-Time Polymerase Chain Reaction
Eva, B., Bitarte, N., Ramírez, N., Zárate, R., & Jesus, G.-F. (2009) · Springer eBooks · doi:10.1007/978-1-4020-9545-0_6 · Cited by 1
MicroRNAs in Development and Progression of Breast Cancer
Thangraju, M., & Jain, A. K. (2014) · Springer eBooks · doi:10.1007/978-1-4899-8065-6_7
MicroRNA Profiling and Its Application in Drug Discovery in Pancreatic Cancer
Ranade, A. R., & Weiss, G. J. (2010) · Springer eBooks · doi:10.1007/978-1-4419-1160-5_9
Involvement of MicroRNAs in Human Cancer: Discovery and Expression Profiling
Negrini, M., & Călin, G. A. (2009) · Springer eBooks · doi:10.1007/978-90-481-2675-0_5
MicroRNAs and Clinical Implications in Cancer
Wittmann, J. (2014) · Springer eBooks · doi:10.1007/978-3-319-03725-7_13
Genome‐Wide Expression Profiling of Human Hepatocellular Carcinoma
Budhu, A., & Wang, X. W. (2009) · doi:10.1002/9780470747919.ch61
Epigenetics and MicroRNAs in Animal Health
Tian, F., & Song, J. (2011) · doi:10.1002/9781119949930.ch9
Tait, I. (2014) · Tuwhera (Auckland University of Technology)
Namwat, N., Loilome, W., & Yongvanit, P. (2012) · Srinagarind Medical Journal (SMJ) - ศรีนครินทร์เวชสาร
Role of microRNAs in mediating pancreatic cancer response to triptolide
MacKenzie, T. N. (2013) · University of Minnesota Digital Conservancy (University of Minnesota)
Caracterização da expressão de microRNAS em carcinoma de mama triplo negativo
Filho, C. M. C. C. (2014) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.5.2014.tde-29102014-165054
CpG Island Hypermethylation, miRNAs, and Human Cancer
Lujambio, A., & Esteller*, M. (2008) · Springer eBooks · doi:10.1007/978-1-4020-8533-8_20
Tian, F. (2012) · University Libraries (University of Maryland)
Gruppen, F. A. (2011) · Utrecht University Repository (Utrecht University)
Genomic Profiling of Human Hepatocellular Carcinoma
Budhu, A., Ji, J., & Wang, X. W. (2009) · Humana Press eBooks · doi:10.1007/978-1-60327-376-3_5
Non-CDH1-Associated Familial Gastric Cancer and Epigenetics Factors
Leite, M., Corso, G., Sousa, S., Carvalho, J., Roviello, F., Oliveíra, C., Figueiredo, C., & Seruca, R. (2013) · Springer eBooks · doi:10.1007/978-94-007-6570-2_10
Regulation of MicroRNA-221/222 Expression in Tamoxifen Resistant Breast Cancer
Thesis, H., & Miller, T. E. (2010)
siRNA ET microRNA : BIOGENESE, MECANISME ET FONCTIONS
Varna, M., & Artenie, V. (2007) · DOAJ (DOAJ: Directory of Open Access Journals)
Application of MicroRNA in the Treatment and Diagnosis of Cervical Cancer
Banno, K., Iida, M., Yanokura, M., Kisu, I., Nakamura, K., Adachi, M., Iwata, T., Tanaka, K., & Aoki, D. (2014) · Springer eBooks · doi:10.1007/978-3-319-05134-5_7
Padmanabhan, R. (2009) · Holmes Museum Of Anthropology (Wichita State University)
Analysis of Circadian Properties and Clock Regulation of Glioma and Breast Cancer Stem Cells
Sharma, V. P. (2014) · OhioLink ETD Center (Ohio Library and Information Network)
Sánchez-Tejada, L. (2016) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)
Construction of a vector system for functional verification of microRNA binding sites
Solheim, E. (2009) · NORA - Norwegian Open Research Archives
Interplay Between Metabolism and Oncogenic Process: Role of microRNAs
Ambedkar, B. R. (2015)
Lynam‐Lennon, N., Gray, S. G., & Maher, S. G. (2012) · Elsevier eBooks · doi:10.1016/b978-0-12-388415-2.00005-6
Discussion and future perspectives
JMVANDONGEN, J. (1996) · Elsevier eBooks · doi:10.1016/b978-012442710-5/50214-8
The Clinical Utility of MicroRNA as a Prognostic Biomarker of Pancreatobiliary Cancers
Lee, K. T. (2016) · Gut and Liver · doi:10.5009/gnl16309
Sharma, S. B. (2015) · The Research Repository @ WVU (West Virginia University) · doi:10.33915/etd.6619
miR-106b-responsive gene landscape identifies regulation of Kruppel-like factor familyPreprint
Wehrkamp, C. J., Natarajan, S. K., Mohr, A. M., Phillippi, M. A., & Mott, J. L. (2016) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/088229
Smith, S. S. (2016) · OpenCommons - UConn (University of Connecticut)
miR-200 family and gastrointestinal tumors
Du, P., & Zhang, Q.-Y. (2011) · World Chinese Journal of Digestology · doi:10.11569/wcjd.v19.i29.3053
The role of microRNAs in mammary tumorigenesis
Barnett, E. (2011) · The Atrium (University of Guelph)
Greco, J. (2013) · TSpace (University of Toronto)
Neoplasia of the Gastrointestinal Tract
Margalit, O., & DuBois, R. N. (2015) · Wiley eBooks · doi:10.1002/9781118512074.ch31
Tomenson, M. (2010) · TSpace (University of Toronto)
Involvement of MicroRNAs in the Regulation of Porcine Follicle Maturation
Pan, B. (2018) · The Atrium (University of Guelph)
Delivery of MicroRNA with CXCR4-Targeted Nanoparticles in Metastatic Cancer Treatment
Xie, Y. (2018) · DigitalCommons@UNMC
The role of RNAs and extracellular vesicles in the radiation response
Jacobs, L. A. (2015) · Radar (Oxford Brookes University) · doi:10.24384/3j7x-yk04
Therapeutic Potential of Pharmacoepigenetics in Cholangiocarcinoma
O’Rourke, C. J., Satriano, L., Oliveira, D. V. N. P., Muñoz-Garrido, P., & Andersen, J. B. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-813939-4.00017-6
Rai, V., Boosani, C. S., & Agrawal, D. K. (2019) · World Academy of Sciences Journal · doi:10.3892/wasj.2019.18
Khan, I., Kerwin, J., Owen, K. A., Griner, E., & Reproducibility Project: Cancer Biology (2015) · eLife · doi:10.7554/elife.08245.003
Advances in the molecular characterization of liver tumors
Matter, M. S., & Andersen, J. B. (2017) · Elsevier eBooks · doi:10.1016/b978-0-323-34062-5.00009-1
Advances in Studies on the Correlation between Circulating Blood MicroRNA and Radiation Dose
刘, 明. (2020) · Advances in Clinical Medicine · doi:10.12677/acm.2020.108250
BaiJu, H., Deng, W., YangChun, X., & Xu, W. (2013)
The Investigative Therapeutic Pipeline for Cholangiocarcinoma: Insights from Model Systems
Maroni, L., & Marzioni, M. (2021) · Springer eBooks · doi:10.1007/978-3-030-70936-5_26
Alpini, G. D., Francis, H., Marzioni, M., Alvaro, D., Gaudio, E., Lorenzini, I., Benedetti, A., & Fava, G. (2010) · Molecular pathology library · doi:10.1007/978-1-4419-7107-4_59
武雪梅, & 肖华胜 (2009) · Science in China Series C-Life Sciences (in Chinese) · doi:10.1360/zc2009-39-9-813
Salter, K. H., Acharya, C. R., Walters, K. S., Redman, R., Anguiano, A., Garman, K. S., Anders, C. K., Mukherjee, S., Dressman, H. K., Barry, W. T., et al. (2011) · PLoS ONE · doi:10.1371/annotation/8f94e479-4161-43a0-a28c-4c0460bb89a4
RetractedSchwartz, S. M. (2018) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.732986432.793553302
(2008) · Science in China Series C-Life Sciences (in Chinese) · doi:10.1360/zc2008-38-10-913
Schwartz, S. M. (2007) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.1087088.540065
MiRNA-200b as a prognostic factor in invasive duct carcinoma
(2015) · SECI Oncology Journal · doi:10.21608/secioj.2015.5700
Giovannetti, E., Funel, N., Peters, G. J., Chiaro, M. D., Erozenci, L. A., Vasile, E., León, L. G., Pollina, L. E., Groen, A., Falcone, A., et al. (2023) · doi:10.1158/0008-5472.c.6500180.v1
Yamamichi, N., Shimomura, R., Inada, K., Sakurai, K., Haraguchi, T., Ozaki, Y., Fujita, S., Mizutani, T., Furukawa, C., Fujishiro, M., et al. (2023) · doi:10.1158/1078-0432.c.6517567
Braconi, C., Valeri, N., Gasparini, P., Huang, N., Taccioli, C., Nuovo, G. J., Suzuki, T., Croce, C. M., & Patel, T. C. (2023) · doi:10.1158/1078-0432.c.6517779
Self-citationBraconi, C., Valeri, N., Gasparini, P., Huang, N., Taccioli, C., Nuovo, G. J., Suzuki, T., Croce, C. M., & Patel, T. C. (2023) · doi:10.1158/1078-0432.c.6517779.v1
Self-citationJiang, J., Gusev, Y., Aderca, I., Mettler, T. A., Nagorney, D. M., Brackett, D. J., Roberts, L. R., & Schmittgen, T. D. (2023) · doi:10.1158/1078-0432.c.6518614.v1
Self-citationMoriyama, T., Ohuchida, K., Mizumoto, K., Yu, J. Q., Sato, N., Nabae, T., Takahata, S., Toma, H., Nagai, E., & Tanaka, M. (2023) · doi:10.1158/1535-7163.c.6531665.v1
Data from MicroRNA expression profiles for the NCI-60 cancer cell panel
Blower, P. E., Verducci, J. S., Lin, S., Zhou, J., Chung, J.-H., Zunyan Dai, Y., Liu, C.-G., Reinhold, W. C., Lorenzi, P. L., Kaldjian, E. P., et al. (2023) · doi:10.1158/1535-7163.c.6531822
MicroRNAs in Liver Regeneration
Yang, D., Möbus, S., Balakrishnan, A., & Sharma, A. D. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-820719-2.00026-0
Karim, H., Negm, O. H., Narmeen, A., & Ilyas, M. (2022) · International Journal of Cancer and Clinical Research · doi:10.23937/2378-3419/1410180
王, 瑞. (2024) · Advances in Clinical Medicine · doi:10.12677/acm.2024.1451703
Elesnawy, M., Elghandour, R., Hasna, H., Fakhroo, A. D., AlSulaiti, B., & Younis, I. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.08.15.608023
Iranmehr, Z., Yasavoli‐Sharahi, H., Ghaemi, F., Miri, S. R., & Ebrahimi, M. (2024) · Research Square · doi:10.21203/rs.3.rs-5416147/v1
Expanding roles of microRNAs in colorectal cancer in the era of immunotherapy
Bilal, A., & Ahmad, S. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-24742-2.00015-0
Lian, Y., Wang, A., Lin, R., Ke, X., Zhan, X., Lu, R., Qian, T., Ghosh, A., Ong, A. A. L., Toh, D. K., et al. (2025) · SSRN Electronic Journal · doi:10.2139/ssrn.5387528
Bile Duct Cancer: From Bench to Bedside – Latest Developments
Trivedi, G., Anshu, A., & Trivedi, A. (2025) · IntechOpen eBooks · doi:10.5772/intechopen.1011837
MicroRNAs as biomarkers in gynecological-mammary cancers
Tadlaoui, K. A., Aqerrout, M., Mharrach, I., & Ennaji, M. M. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-30225-1.00056-7
Genetics and Epidemiology of Cholangiocarcinoma
Blechacz, B. R. A., & Gores, G. J. (2010) · Springer eBooks · doi:10.1007/978-1-4419-6082-5_5
Role of Epigenetics in the Pathogenesis of Acquired Cholesteatoma—A State of the Art Review
Brar, T. K., Catanzarite, A., Arya, P., White, M. S., & Govil, N. (2026) · Otolaryngology · doi:10.1002/ohn.70135
Merdrignac, A. (2019) · theses.fr (ABES) · doi:10.70675/0fb17c97z89c5z4982z96adzb83f522b62aa
Elesnawy, M., Elghandour, R., Hasna, H., Fakhroo, A. D., AlSulaiti, B., & Younis, I. (2026) · iScience · doi:10.1016/j.isci.2026.115726
Delipınar, S. D., Ekmekçi, H., Gungor, Z. B., Gezen‐Ak, D., Alaylıoğlu, M., Akkan, A. G., Dogan, M. A., Aydın, A. K., Güzel, E., & Seçkin, İ. (2026) · Journal of Molecular Histology · doi:10.1007/s10735-026-10791-6
Roncoroni, L., Terrazzan, A., Elli, L., Ancona, P., Olaizola, P., Tabano, S. M., Colapietro, P., Gamberini, F., Orlandi, C., Aguiari, G., et al. (2026) · Experimental and Molecular Pathology · doi:10.1016/j.yexmp.2026.105059
Applications and advances of bile-based omics technologies in the diagnosis of cholangiocarcinoma
Zhu, T., Xing, J., Huang, Z., Wang, S., Li, D., Sang, X., Ning, C., Zhu, C., Zheng, Y., & Zhao, H. (2026) · Journal of Zhejiang University SCIENCE B · doi:10.1631/jzus.b2500181
Use of chromatin changes as biomarkers
Hlady, R. A., & Robertson, K. D. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-19001-8.00027-1
MicroRNAs and Discovery of New Targets
Tsuchiya, S., Okuno, Y., & Tsujimoto, G. (2008) · Humana Press eBooks · doi:10.1007/978-1-60327-088-5_4
MicroRNAs in Vascular Neointimal Lesion Formation
Zhang, C. (2008) · Springer eBooks · doi:10.1007/978-1-4020-8533-8_18
Metadata
- Authors
- Meng, F., Henson, R., Lang, M., Wehbe, H., Maheshwari, S., Mendell, J. T., Jiang, J., Schmittgen, T. D., & Patel, T.
- Affiliations
- Texas A&M University System (US)
- Johns Hopkins University (US)
- The Ohio State University (US)
- Corresponding author
- Patel, Tushar
- Venue
- Gastroenterology
- Publisher
- Elsevier BV
- Published
- 2006-06
- Volume
- 130
- Issue
- 7
- Pages
- 2113-2129
- ISSN
- 0016-5085 (ISSN-L)
- OpenAlex
- W1990645475
- Cited by
- 984
- References
- 44
- Citations by year
- 2026: 9 · 2025: 19 · 2024: 13 · 2023: 24 · 2022: 26 · 2021: 27 · 2020: 22 · 2019: 28 · 2018: 27 · 2017: 49 · 2016: 60 · 2015: 64 · 2014: 86 · 2013: 76 · 2012: 65
- FWCI
- 27.56
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Gastroenterology (publishedVersion)
- PubMed (publishedVersion)
- OakTrust (Texas A&M University Libraries) (submittedVersion)
- Funders
- National Institutes of Health
- National Institute of Diabetes and Digestive and Kidney Diseases (DK-069370, R01DK069370)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › MicroRNA in disease regulation
- Health Sciences › Medicine › Surgery › Cholangiocarcinoma and Gallbladder Cancer Studies
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer-related molecular mechanisms research
- Keywords
- microRNA, cholangiocarcinoma, miR-21, miR-200b, miR-141, gemcitabine, chemotherapy response, tumor cell proliferation, PTEN, PI3K signaling, apoptosis, miRNA expression profiling, cholangiocytes, xenografts, therapeutic target
- MeSH terms
- Gemcitabine, Animals, Deoxycytidine, Humans, Male, Mice, Nude, Probability, Sampling Studies, Sensitivity and Specificity, Transfection, Transplantation, Heterologous, Blotting, Northern, Blotting, Western, Gene Expression Regulation, Neoplastic, Apoptosis, Cholangiocarcinoma, Reverse Transcriptase Polymerase Chain Reaction, Oligonucleotide Array Sequence Analysis, Gene Expression Profiling, MicroRNAs, Cell Line, Tumor, Cell Proliferation, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
